









Markets
/
Stocks
/
nasdaq-phar
/

Pharming Group NV

PHAR

View Detailed Chart

10.960USD

-0.150-1.35%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Pharming Group NV

10.960

-0.150-1.35%

Overview Company Financials

Financials

Intraday

30m

Today

-1.35%

5 Days

+6.82%

1 Month

+3.59%

6 Months

+33.66%

Year to Date

+8.89%

1 Year

+51.17%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

STRONG BUY

Current Rating

6.118

Target Price

-44.18%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Pharming Group NV

PHAR

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(2)

Buy(8)

Indicators

Sell(1)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.196

Neutral

RSI(14)

57.741

Neutral

STOCH(KDJ)(9,3,3)

73.029

Buy

ATR(14)

0.444

High Vlolatility

CCI(14)

182.999

Buy

Williams %R

18.808

Overbought

TRIX(12,20)

-0.176

Sell

StochRSI(14)

86.735

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

10.404

Buy

MA10

10.260

Buy

MA20

10.226

Buy

MA50

10.694

Buy

MA100

9.697

Buy

MA200

9.236

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Ticker SymbolPHAR

CompanyPharming Group NV

CEODr. Sijmen (Sijmen) De Vries, M.D.

Websitehttps://www.pharming.com/